GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JBM (Healthcare) Ltd (HKSE:02161) » Definitions » YoY Rev. per Sh. Growth

JBM (Healthcare) (HKSE:02161) YoY Rev. per Sh. Growth : 34.44% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is JBM (Healthcare) YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. JBM (Healthcare)'s YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 was 34.44%.

JBM (Healthcare)'s Revenue per Share for the six months ended in Sep. 2024 was HK$0.48.

JBM (Healthcare) YoY Rev. per Sh. Growth Historical Data

The historical data trend for JBM (Healthcare)'s YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JBM (Healthcare) YoY Rev. per Sh. Growth Chart

JBM (Healthcare) Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial 24.13 14.29 -6.97 28.63 25.68

JBM (Healthcare) Semi-Annual Data
Mar18 Mar19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.00 31.28 35.85 17.55 34.44

JBM (Healthcare) YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

JBM (Healthcare)'s YoY Rev. per Sh. Growth for the fiscal year that ended in Mar. 2024 is calculated as:

YoY Rev. per Sh. Growth (A: Mar. 2024 )
=(Revenue per Share (A: Mar. 2024 )-Revenue per Share (A: Mar. 2023 ))/ | Revenue per Share (A: Mar. 2023 ) |
=(0.734-0.584)/ | 0.584 |
=25.68 %

JBM (Healthcare)'s YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Sep. 2024 )
=(Revenue per Share (Q: Sep. 2024 )-Revenue per Share (Q: Sep. 2023 )) / | Revenue per Share (Q: Sep. 2023 )) |
=(0.484-0.36)/ | 0.36 |
=34.44 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JBM (Healthcare) YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of JBM (Healthcare)'s YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

JBM (Healthcare) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JBM (Healthcare) Ltd (HKSE:02161) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
HKSE:02552 HKSE:02348 HKSE:02633 HKSE:01061 HKSE:08049 HKSE:00950 HKSE:00239 HKSE:03737 HKSE:03839 HKSE:00897 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
108 Wai Yip Street, Units 808-811, 8 floor, C-Bons International Centre, Kwun Tong, Kowloon, Hong Kong, HKG
Website
https://www.jbmhealthcare.com.hk
JBM (Healthcare) Ltd markets and distributes healthcare products. The company's operating segment includes Branded medicines; Proprietary Chinese medicines and Health and wellness products. It generates maximum revenue from the Proprietary Chinese medicines segment. The Proprietary Chinese medicines segment develops, manufactures, and distributes registered Chinese medicines composed solely of any Chinese herbal medicines specified in the Chinese Medicine Ordinance, or any materials of herbal, animal, or mineral origin customarily or widely used by the Chinese. Geographically, it derives a majority of its revenue from Hong Kong.
Executives
Sum Kwong Yip, Derek
Queenshill Development Limited
Ubs Trustees (b.v.i.) Limited
Kingshill Development Group Inc
Lincoln's Hill Development Limited
Yun Nan Bai Yao Ji Tuan Gu Fen You Xian Gong Si
New Heritage Healthcare Limited 2101 Beneficial owner
Gavett Limited 2201 Interest of corporation controlled by you
United Islands Group Limited 2201 Interest of corporation controlled by you
Fortstar Limited 2201 Interest of corporation controlled by you
Tao Richard 2201 Interest of corporation controlled by you
Hon Hing Tong Patricia 2202 Interest of your spouse
Tao Paul 2201 Interest of corporation controlled by you
Choi Siu Ping 2202 Interest of your spouse
Longjin Investments Limited 2101 Beneficial owner

JBM (Healthcare) Headlines

No Headlines